Jennison Associates’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.1M Buy
76,863
+63,685
+483% +$3.4M ﹤0.01% 414
2025
Q1
$533K Buy
+13,178
New +$533K ﹤0.01% 548